Articles tagged "Kidney transplantation"

2015 American Transplant Congress
MYH9 Polymorphic Variants and Chronic Lesions in Transplanted Kidney Biopsy
J. Pazik,¹ M. Oldak,² Z. Lewandowski,³ D. Ozieblo,⁴ K. Michalska,⁵ A. Perkowska Ptasińska,¹ A. Sadowska,¹ M. Nowaczyk,⁵ J. Malejczyk,⁴ M. Durlik.¹
¹Department of Nephrology and Transplantation Medicine, Medical University of Warsaw, Warsaw, Poland; ²Institute of Physiology and Pathology of Hearing, Warsaw, Poland; ³Department of Epidemiology, Medical University of Warsaw, Warsaw, Poland; ⁴Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland; ⁵Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland.
MYH9 encoding a non-muscle myosin heavy chain IIA is expressed in podocytes, mesangial, tubular, capillary endothelial cells and vascular wall. Intronic variants of MYH9 associate…
2015 American Transplant Congress
Kidney Transplant Outcomes in Patients With Amyloidosis
J. Verbesey, M. Cooper, P. Weems, A. Gilbert, M. Grafals, C. Nilubol, J. Moore, S. Ghasemian, B. Javaid.
Kidney and Pancreas Transplant Program, MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC.
Objective: Analyze kidney allograft outcomes in patients with kidney failure due to amyloidosis, and compare kidney transplant survival to patients with other causes of kidney…
2015 American Transplant Congress
Center Volume Is Associated With Early Graft Failure After Living Donor Kidney Transplantation
B. Shelton, P. MacLennan, R. Reed, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.
Surgery/Transplantation, University of Alabama at Birmingham, Birmingham, AL.
Introduction: The correlation between center volume and outcomes has been established within general surgery and is most pronounced within the context of high-risk, low-volume procedures.…
2015 American Transplant Congress
Change in Physical Function Following Kidney Transplantation
E. Lorenz, A. Cheville, B. Kotajarvi, F. Cosio, N. LeBrasseur.
Mayo Clinic, Rochester, MN.
Introduction: Improved physical function is associated with increased survival in the general population. Little is known about whether physical function improves following kidney transplant. The…
2015 American Transplant Congress
Differentially Expressed Genes in Immunosuppressed Kidney Transplant Recipients
C. Dorr,¹ B. Wu,² W. Guan,² A. Muthusamy,¹ K. Sanghavi,³ P. Jacobson,³ W. Oetting,³ D. Schladt,¹ R. Remmel,³ J. Maltzman,⁵ A. Matas,⁴ For DeKAF Genomics Investigators,¹ A. Israni.¹
¹Medicine, MMRF, HCMC, Minneapolis, MN; ²Biostatistics, University of MN, Minneapolis, MN; ³Pharmacy, University of MN, Minneapolis, MN; ⁴Surgery, University of MN, Minneapolis, MN; ⁵Medicine, University of PA, Philadelphia, PA.
Introduction: In our effort to personalize immunosuppressive therapies we performed RNA sequencing (RNAseq) to identify differentially expressed genes (DEGs) after kidney transplant (tx) and the…
2015 American Transplant Congress
Controlling for Socioeconomic Barriers Reduces Racial Disparities in Transplant Pursuit
A. Waterman,¹ J. Peipert,¹ C. Kynard-Amerson,¹ A.-M. McSorley,¹ A. Paiva,² M. Robbins,² L. Peace.³
¹David Geffen School of Medicine, UCLA, Los Angeles, CA; ²University of Rhode Island, Kingston, RI; ³Missouri Kidney Program, Columbia, MO.
Compared to White dialysis patients, Black patients experience more socioeconomic barriers (SEBs) including higher financial insecurity and worse health insurance. To examine how SEBs affect…
2015 American Transplant Congress
Kidney Transplantation from Expanded Criteria Deceased Donors With Terminal Acute Kidney Injury
J. Hwang,¹ M.-H. Kim,¹ K. Jun,¹ S. Ahn,¹ S. Kim,¹ S. Park,¹ S. Kim,² J. Kim,¹ C. Yang,² I. Moon.¹
¹Surgery, The catholic University of Korea, Seoul, Korea; ²Internal Medicine, The catholic iniversity of Korea, Seoul, Korea.
We investigated clinical outcomes of kidney transplantation (KT) from deceased donors with terminal acute kidney injury (AKI) defined acute kidney injury network (AKIN) criteria and…
2015 American Transplant Congress
Opportunities in Tacrolimus Therapeutic Drug Monitoring
N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.
Department of Pharmacy, NewYork-Presbyterian Hospital, NY.
Tacrolimus requires diligent therapeutic drug monitoring (TDM) to maintain appropriate serum concentrations after transplant. To optimize efficacy & minimize toxicity frequent levels are drawn, commonly…
2015 American Transplant Congress
The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant
J. Benken,¹ S. Akkina,² E. Benedetti.³
¹Pharmacy Practice, Univ. of IL-Chicago, Chicago, IL; ²Dept. of Medicine, Nephrology, Univ. of IL-Chicago, Chicago, IL; ³Dept. of Surgery, Univ. of IL-Chicago, Chicago, IL.
Introduction:ABO incompatible (ABOi) and positive crossmatch (PXM) living donor kidney transplantation is a life-saving alternative to dialysis. A variety of protocols exist utilizing plasmapheresis (PP)…
2015 American Transplant Congress
Landscape of Non-Directed Live Donors
K. Kumar, X. Luo, A. Massie, T. Purnell, J. Tonascia, E. King, D. Segev.
Johns Hopkins, Baltimore, MD.
Background: The use of kidneys from Non-directed live donors (NDLD) among transplant centers in the US is unknown and the recipient selection remains varied. We…